Living with depression can feel like you are carrying extra weight. It can make mundane activities feel hopeless and cause you to lose interest in things you once enjoyed. This burden can impact every aspect of your life, including relationships, career, and self-esteem.
So, what is the success rate of Spravato? Many people ask this question when traditional medications have not brought them relief from depression. Depression is one of the most common mental health disorders in the U.S., and if you are struggling, you are not alone. Spravato treatment offers a new path for those who have not found success with other treatments. Our board-certified psychiatry providers are here to help you understand what to expect and guide you toward individualized care options..
Spravato is an advanced treatment for major depressive disorder (MDD) that is particularly successful for those who have not found relief from traditional medications, which we call treatment-resistant depression (TRD). Spravato contains esketamine, which acts on the glutamate receptors in the brain to boost mood and repair connections damaged by chronic depression, and is administered as a nasal spray.
This innovative medication works differently from antidepressants, and you can often expect to feel its results more quickly. This rapid onset makes Spravato a good choice for those experiencing emotional crisis or suicidal thoughts. However, if you are in acute distress, we recommend that you seek immediate medical attention.
Spravato is FDA-approved to manage treatment-resistant depression (TRD) and major depressive disorder (MDD), with or without suicidal ideation or behavior. This means the FDA has thoroughly evaluated this innovative treatment and determined it to be safe and effective for appropriate patients.
Clinical research strongly supports the benefits of Spravato. Studies show that about 70 percent of patients who follow the recommended dosing schedule experience a meaningful reduction in depressive symptoms. In another study, 88 percent of patients reported that after three months of treatment their symptoms had nearly disappeared. Many individuals also continue to see improvement for two years or more with ongoing care.
This medication is the only FDA-approved ketamine-based therapy currently available for depression, making it a safe and effective option for many patients. Spravato is self-administered under supervision in our office, and you will remain for at least two hours after each dose. During that time, you will be closely monitored by Spravato-certified treaters and an APRN to ensure your safety and comfort.
While most people generally tolerate Spravato well, you may feel some side effects during treatment, which may include:
These symptoms are typically mild and resolve quickly. Before beginning sessions, we will ask you about your medical and psychiatric history to ensure you are a good candidate for treatments.
Spravato offers a powerful alternative for those who feel confined in their search for mental health relief. With extensive clinical support, this advanced treatment helps individuals rediscover clarity, energy, and emotional balance.
If you are wondering what is the success rate of Spravato and whether this treatment may be right for you, contact our team today to schedule your initial appointment. We are here to help you understand what to expect from treatments and guide you through your journey toward wellness at every step.
